Various groups have considered the question of who should get theinfluenza vaccine. In April 2012, the World Health Oganization's (WHO)Strategic Advisory Group of Experts(SAGE) on immunisationrecommendedthat pregnant women were the most important risk group for seasonal influenza vaccination. It also...
prior influenza vaccine was associated with improved survival.4 The clinical benefit of influenza vaccination, indications and contraindications, and risk groups who are likely to benefit most are well documented in the Australian ImmunisationHandbook5andbytheWorldHealthOrganization6 and the Centers for Dise...
but have not yet been licensed in Australia.LAIV are given by squirting the vaccine into the nose (as a nasal spray), so injection is not required. In years where the surface particles in the vaccine do not match the particles on the...
To assess the influenza immunisation rate for 2005 in patients aged 65 years and over admitted to a general medical ward at Auckland City Hospital, New Zealand; to identify factors associated with receiving this vaccine; and to assess whether particular patient groups have a low influenza immunisati...
Vaccines and Vaccine Delivery Systems: Experience with HSV, Influenza and Mucosal Routes of ImmunisationThe primary route of entry into the body for many viruses, including herpes simplex virus type 2 (HSV-2) and the influenza virus, is via mucosal surfaces. It follows that, depending on the ...
Although not a prime public health concern, seasonal influenza remains a challenge in the United Arab Emirates (UAE). This problem is augmented by the fact that the percentage of the population intending to take the yearly seasonal influenza vaccine is r
Low interim influenza vaccine effectiveness, Australia, 1 may to 24 September 2017. Euro Surveill. 2017;22:2–8. Google Scholar Australian Government Department of Health: The Australian Immunisation Handbook. 2019. https://immunisationhandbook.health.gov.au/. Accessed 10 Apr 2019. Voirin N, ...
Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis. BMJ 1987; 294: 348.Versluis DJ, Beyer WE, Masurel N, Weimar W, Kramer P, Diderich PP. Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis. British medical journal (...
A vaccine composition may include material for a single immunisation, or may include material for multiple immunisations (i.e. a ‘multidose’ kit). The inclusion of a preservative is preferred in multidose arrangements. As an alternative (or in addition) to including a preservative in multidose...
The choice of these three vaccinations was based on their heterogeneity: immunisation against HPV concerns adolescents and protects them against clinical disease and complications that appear over their lifetime, the Herpes-Zoster vaccine protects against an individual risk of disease and it is also rec...